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Although activity-dependent transcription represents a crucial mechanism for long-lasting experience-dependent changes in the
hippocampus, limited data exist on its contribution to pathological conditions. We aim to investigate the influence of chronic stress
on the activity-dependent transcription of brain-derived neurotrophic factor (BDNF).The ex vivomethodology of acute stimulation
of hippocampal slices obtained from rats exposed to chronicmild stress (CMS)was used to evaluate whether the adverse experience
may alter activity-dependent BDNF gene expression. CMS reduces BDNF expression and that acute depolarization significantly
upregulates total BDNF mRNA levels only in control animals, showing that CMS exposure may alter BDNF transcription
under basal conditions and during neuronal activation. Moreover, while the basal effect of CMS on total BDNF reflects parallel
modulations of all the transcripts examined, isoform-specific changes were found after depolarization. This different effect was
also observed in the activation of intracellular signaling pathways related to the neurotrophin. In conclusion, our study discloses a
functional alteration of BDNF transcription as a consequence of stress. Being the activity-regulated transcription a critical process
in synaptic and neuronal plasticity, the different regulation of individual BDNF promoters may contribute to long-lasting changes,
which are fundamental for the vulnerability of the hippocampus to stress-related diseases.
1. Introduction
One of the most remarkable features of the hippocampus is
its ability to shape its functions and adapt to environmental
changes through different mechanisms allowing neurons to
adjust their properties according to their activity. These
characteristics are crucial not only because of the role of this
brain region in synaptic plasticity in the context of learning
and memory [1], but also considering that a deficit in this
skill might result in pathologic conditions. For example,
given the high sensitivity to stress of the hippocampus [2–
4], different studies have shown an association between
hippocampal dysfunctions and stress-related diseases, such
as major depression or posttraumatic stress disorders [5, 6].
Activity-regulated transcription plays a crucial role in hip-
pocampal function [7] and may be altered under pathologic
conditions [8]. A key gene for these mechanisms encodes
the neurotrophin brain-derived neurotrophic factor (BDNF)
that, in addition to supporting neuronal survival during CNS
development [9, 10], represents an important mediator of
neuronal plasticity in adulthood [11, 12]. Activity-dependent
regulation of BDNF occurs through complex transcriptional
mechanisms, with at least eight distinct promoters that drive
the transcription of distinct mRNAs, each containing an
alternative 5I exon spliced to a common 3I coding exon
[13–15]. Although Bdnf promoters are differently responsive
to neuronal activation [16–18], limited data are available
to explain how pathological conditions may affect activity-
dependent BDNF transcription. Therefore, the aim of our
study was to investigate the activity-dependent transcription
of the neurotrophin in the hippocampus of rats exposed to
chronic stress. In depth, we used the ex vivo methodology
of the acute stimulation of hippocampal slices obtained
from rats exposed to a chronic unpredictable stress (CMS)
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Figure 1: Experimental paradigm. Adult male Sprague Dawley rats were subjected to the stress procedure for 3 weeks and then sacrificed by
decapitation after 24 hours from the last stressor.The brains were rapidly removed for hippocampal slices preparation.The slices, after a period
of adaptation in oxygenatedKrebs buffer, were incubated for 15minutes in presence or absence of KCl 50mM to test the effects of ex vivo depo-
larization. After the incubation period, hippocampal slices were collected, frozen on dry ice, and stored at −80∘C until the molecular analyses.
paradigm to evaluate the different responsiveness to depo-
larization in terms of BDNF expression and signaling. This
experimental approach replicates many aspects of the in vivo
context as slices largely preserve the tissue architecture of
the brain region they originated from and maintain neu-
ronal activities with intact functional local synaptic circuitry.
Hence, they are ideal platforms for dissection of molecular
pathways underlying neuronal dysfunction.
2. Methods
General reagents were purchased from Sigma-Aldrich
(Milan, Italy), and molecular biology reagents were
obtained from Applied Biosystems Italia (Monza, Italy),
Bio-Rad Laboratories S.r.l. Italia (Segrate, Italy), Santa Cruz
Biotechnology (Santa Cruz, CA, USA), and Cell Signaling
Technology (Danvers, MA, USA).
2.1. Animals. Adultmale Sprague-Dawley rats (Charles River,
Calco, Italy) weighing 300–350 g were used throughout the
experiments. Rats were housed in groups of 3 per cage under
standard conditions (12 h light/dark cyclewith food andwater
ad libitum) and were exposed to daily handling for 2 weeks
before any treatment. All animal handling and experimental
procedures were approved by the University of Milan Insti-
tutional Animal Care and Use Committee and adhered to
the Italian legislation on animal experimentation (Decreto
Legislativo 116/92), the EU (EU Directive 2010/63/EU), and
the National Institutes of Health Guide for the Care and Use
of Laboratory Animals. All efforts were made to minimize
animal suffering and to reduce the number of animals used.
2.2. Chronic Mild Stress Paradigm. For chronic mild stress,
animals were randomly divided into stressed and no-stressed
groups (𝑛 = 6 in each experimental group). Sham (no-
stressed) animals were kept undisturbed in their home cages
during the entire experiment except for handling manipu-
lation every 2 days during weighing, while stressed (CMS)
rats were instead exposed for 3 weeks to a variable sequence
of mild, unpredictable stressors, whose application started at
different times every day to minimize habits and therefore
predictability.The stressors usedwere the following: 24 h food
deprivation, isolation overnight, 2 h restraint, 24 h empty
water bottle, soiled cage overnight, light on overnight, and
light on and overcrowding overnight. The impact of CMS
was demonstrated by a significant loss of body-weight gain,
paralleled by reduced food and water consumption, as well
as by reduced preference for sucrose solution with respect
to control animals [19]. Twenty-four hours after having
been subjected to the last stressor, animals were sacrificed
by decapitation and the brains rapidly removed for the
hippocampal slices preparation (Figure 1).
2.3. Preparation of Hippocampal Slices. Hippocampal slices
were prepared (Figure 1) as described by Gardoni and col-
leagues [20]. Briefly, removed brainswere immediately placed
into chilled (4∘C) oxygenatedKrebs buffer and after removing
themeninges, hippocampi were rapidly dissected and quickly
sliced with a McIlwain tissue chopper. The slices (300 𝜇m)
were then placed for 30 minutes in custom-made chambers
continuously equilibrated with O
2
95%–CO
2
5% (v/v) oxy-
genatedKrebs buffer. To induce activity-dependent transcrip-
tion, potassium chloride depolarization was used. After the
equilibration period, slices prepared by CTRL and STRESS
rats were incubated for 15min in presence or absence of KCl
50mM before being collected, frozen on dry ice, and stored
at −80∘C until the molecular analyses. The 𝑛 for the two dif-
ferent experimental conditions was 6 for acute depolarization
treatment and 3 for the physiological situation (Krebs buffer).
2.4. RNA Preparation and Quantification of BDNF mRNA
Expression by Real-Time RT Quantitative PCR. In order
to measure BDNF mRNA levels, total RNA was isolated
from hippocampal slices by single step guanidinium isoth-
iocyanate/phenol extraction using PureZol RNA isolation
reagent (Bio-Rad Laboratories S.r.l. Italia) according to the
manufacturer’s instructions and quantified by spectropho-
tometric analysis. The samples were then processed for
real-time polymerase chain reaction (PCR) to assess BDNF
mRNA levels as previously reported [21]. Briefly, a 2 𝜇g
aliquot of each sample was treated with DNase to avoid DNA
contamination and subsequently reverse transcribed using
a High-Capacity cDNA Archive commercial kit (Applied
Biosystems Italia, Monza, MI, Italy). The real-time PCR
reaction was performed using the ABI Prism 7000 Sequence
Detection System (Applied Biosystems Italia, Monza, MI,
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Italy)with theTaqManGeneExpressionMasterMix (Applied
Biosystems Italia, Monza, MI, Italy) and the following
TaqMan Gene Expression Assay purchased from Applied
Biosystems:
Total Bdnf : ID Rn02531967 s1; Bdnf transcript IV: ID
Rn01484927 m1; Bdnf transcript VI: ID Rn01484928 m1;
Bdnf transcript IXa forward primer: TGGTGTCCCCAA-
GAAAGTAA and reverse primer: CACGTGCTCAAAAGT-
GTCAG.
After an initial step at 50∘C for 2min and at 95∘C for
10min, 40 cycles of PCR were performed. Each PCR cycle
consisted of heating the samples at 95∘C for 15 s to enable
the melting process and then for 1min at 60∘C for the
annealing and extension reaction. Each samplewas assayed in
duplicate using two independent retrotranscription products.
A comparative cycle threshold (Ct) method was used to
determine the relative target gene expression. Data have been
expressed as percentage calculated from the expression of the
target genes normalized on rat glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) gene expression as control gene
(ID GAPDH TaqMan probe: Rn99999916 s1).
2.5. Preparation of Protein Extracts. Hippocampal slices were
homogenized in a glass-glass potter in cold 0.32M sucrose
buffer pH 7.4 containing 1mM HEPES, 0.1mM EGTA,
and 0.1mM PMSF, in presence of commercial cocktails of
protease (cod. 11697498001, Roche, Monza, Italy) and phos-
phatase (cod. P5726, Sigma-Aldrich) inhibitors. The total
homogenate (H) was clarified at 1000 g for 10min obtaining a
pellet (P1) corresponding to the nuclear fraction, which was
resuspended in a buffer (20mM HEPES, 0.1mM DTT, and
0.1mMEGTA) supplemented with protease and phosphatase
inhibitors. Total protein content was measured according to
the Bradford ProteinAssay procedure (Bio-Rad,Milan, Italy),
using bovine serum albumin as calibration standard.
2.6. Western Blot Analysis. By Western blot analysis, protein
extracts were used to assess the phosphorylated and the
total levels of several components of BDNF-related signaling
pathways in the homogenate (ERK1/2, AKT, and GSK-3𝛽)
and of the transcription factor CREB in the nuclear fraction.
The same amounts of total protein for all the samples
(10 𝜇g for ERK1/2, AKT, and GSK-3𝛽; 20𝜇g for CREB)
were run on an SDS-8% polyacrylamide gel under reducing
conditions and then electrophoretically transferred onto
nitrocellulose membranes (Bio-Rad, Milan, Italy). The blots
were blocked with 10% nonfat dry milk and then incubated
with the primary antibodies, following the manufacturer’s
instructions, as summarized inTable 1.Membraneswere then
incubated for 1 h at room temperature with the appropriate
secondary antibody (see Table 1); immunocomplexes were
visualized by chemiluminescence, using the ECL Western
blotting kit (AmershamLife Sciences,Milan, Italy), according
to the manufacturer’s instructions.
Results were standardized to 𝛽-actin as control protein,
which was detected by evaluating the band density at 43 kDa
after probing the membranes with a polyclonal antibody
(Sigma, dilution 1 : 10000) followed by a 1 : 10000 dilution of
Table 1: Antibodies conditions used in the Western blot analyses.
Gene Primary antibody Secondary antibody
Phospho-ERK1/2
Y204/Y187
(42–44 kDa)
1 : 1000 (Cell
Signaling; #4370)
4∘C, O/N
Anti-mouse,
1 : 2000, RT, 1 h
ERK1/2
(42–44 kDa)
1 : 5000 (Sigma;
M3807),
RT, 2 h
Anti-rabbit,
1 : 5000, RT, 1 h
Phospho-CREB S133
(43 kDa)
1 : 1000 (Cell
Signaling; #4276),
4∘C, O/N
Anti-rabbit,
1 : 2000, RT, 1 h
CREB
(43 kDa)
1 : 1000 (Cell
Signaling; #9197),
4∘C, O/N
Anti-rabbit,
1 : 2000, RT, 1 h
Phospho-AKT S473
(60 kDa)
1 : 1000 (Cell
Signaling; #4060),
4∘C, O/N
Anti-rabbit,
1 : 2000, RT, 1 h
AKT
(60 kDa)
1 : 1000 (Cell
Signaling; #9272),
RT, 2 h
Anti-rabbit,
1 : 1000, RT, 1 h
Phospho-GSK3𝛽 S9
(46 kDa)
1 : 1000 (Cell
Signaling; #9336),
4∘C, O/N
Anti-rabbit,
1 : 5000, RT, 1 h
GSK3𝛽
(46 kDa)
1 : 2500 (BD
Transduction;
610201)
RT, 2 h
Anti-mouse,
1 : 5000, RT, 1 h
𝛽-ACTIN
1 : 10000 (Sigma;
A5441),
RT, 1 h
Anti-mouse,
1 : 10000, RT, 1 h
peroxidase-conjugated anti-mouse IgG (Sigma). Quantifica-
tion of the immunoblots was performed using Quantity One
software (Bio-Rad).
2.7. Statistical Analyses. Behavioral data were analyzed with
Student’s t-test (weight gain, panel A) and with the one-
way analysis of variance (ANOVA) (weight and cage food
consumption, panels B and C). Molecular data were analyzed
with two-way ANOVA, with stress (No Stress versus Stress)
and depolarization (KCl 5mM versus KCl 50mM) as inde-
pendent factors and mRNA or protein levels as dependent
variables. When needed, further differences were analyzed
by Single Contrast post hoc test (SCPHT). Significance was
assumed for 𝑃 < 0.05. For graphic clarity, data are presented
as means percent ± standard error (SEM) of control group,
namely, hippocampal slices obtained from no-stressed rats
and incubated with KCl 5mM (the same concentration in
Krebs buffer).
3. Results
3.1. Effects of CMS on Body Weight. We first established the
effectiveness of the adverse manipulation by measuring body
weight. As shown in Figure 2(a), animals exposed to 3 weeks
of CMS showed significantly less weight gain when compared
with control animals (𝑃 < 0.001, Student’s t-test) starting
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Figure 2: Effects of CMS on weight gain and food consuming behavior. Animals subjected to the stress procedure showed a decrease in body
weight, presented as a direct comparison with the control group at 21 days (a) and as a time course during the stress period (b). (c) Showing
the profile of food consumption during the 21 days of CMS procedure. ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001 versus No Stress animals. Student’s t-test
and one-way ANOVA.
from the third day of stress (Figure 2(b), one-way ANOVA),
an effect that may be due also to the reduction of food
consumption (Figure 2(c), one-way ANOVA).
Moreover, we previously showed that the exposure to 3
weeks of CMS induced a significantly reduced preference for
sucrose solution [19].These changes are clear indicators of the
efficacy of the stressful manipulation.
3.2. Analysis of Bdnf Gene Expression. As a first step, we
evaluated the effect of chronic stress on total Bdnf (exon
IX) gene expression and the CMS paradigm was found to
significantly modulate the neurotrophin (𝐹
1,18
= 32.240,
𝑃 < 0.001; ANOVA). In deep, as shown in Figure 3(a),
total Bdnf mRNA levels were reduced in hippocampal slices
prepared from stressed rats (−39% versus No Stress/KCl
5mM, 𝑃 < 0.001; SCPHT). When hippocampal slices were
exposed to depolarizing concentration of KCl, total Bdnf
mRNAs were significantly modulated (𝐹
1,18
= 7.888, 𝑃 <
0.01). Indeed, BDNF expression increased in slices obtained
from unstressed rats (+51% versus No Stress/KCl 5mM, 𝑃 =
0.01; SCPHT),whereas no changeswere found in stressed rats
(+9% versus Stress/KCl 5mM, 𝑃 > 0.05; SCPHT). In order
to gain further insight into the different responsiveness to
KCl, the expression profile of some neurotrophin transcripts,
namely, exons IV, VI, and IXa, was investigated. Similar to
what was observed for total Bdnf, chronic stress significantly
reduced the expression of all these isoforms (Figure 3(b),
isoform IV: −40%, 𝐹
1,15
= 80.819, 𝑃 < 0.001; Figure 3(c),
isoform VI: −31%, 𝐹
1,15
= 12.719, 𝑃 < 0.01; Figure 3(d),
isoform XIa: −42%, 𝐹
1,15
= 29.455, 𝑃 < 0.001). Their gene
expression was also affected by depolarization (isoform IV:
𝐹
1,15
= 15.548,𝑃 < 0.01; isoformVI:𝐹
1,15
= 16.542,𝑃 < 0.01;
isoform XIa: 𝐹
1,15
= 21.278, 𝑃 < 0.001), but with different
effect. Incubation with 50mM KCl significantly increased
isoform IV mRNA levels in control rats (Figure 3(b) +44%
versus No Stress/KCl 5mM, 𝑃 < 0.001; SCPHT) but not in
stressed animals (+7% versus Stress/KCl 5mM). Conversely,
under depolarizing conditions the expression of exon VI
was upregulated in stressed rats (Figure 3(c) +33% versus
Stress/KCl 5mM, 𝑃 < 0.01; SCPHT) but not in the control
group (+4% versus No Stress/KCl 5mM). Lastly, isoform
IXa mRNA levels were increased after depolarization in both
unstressed (+36% versus Stress/KCl 5mM, 𝑃 < 0.01) and
stressed animals (+36% versus Stress/KCl 5mM, 𝑃 < 0.05),
as shown in Figure 3(d).
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Figure 3: Analyses of BDNF gene expression. The mRNA levels of the total form of BDNF (a), BDNF isoform IV (b), isoform VI (c), and
isoform IXa were measured by qRT-PCR in hippocampal slices obtained from unstressed (No Stress) or chronically stressed (Stress) rats
exposed to KCl-induced depolarization (KCl 50mM). The data, shown as a percentage referring to control group (No Stress/KCl 5 nM), are
the mean ± SEM of independent determinations. ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001 versus No Stress animals/KCl 5 nM; #𝑃 < 0.05, ##𝑃 < 0.01 versus
Stress/KCl 5 nM. Two-way ANOVA with SCPHT.
3.3. Analysis of BDNF Mediated Signaling. Afterwards, we
examinedwhether the different activity-dependent transcrip-
tion of Bdnf seen in CMS rats was paralleled by changes in
signaling pathways related to the neurotrophin. We analyzed
the expression and the activation (phosphorylated form) of
ERK1/ERK2 (Tyr204/Tyr187), Creb (Ser133), and AKT (Ser473)
and its downstream target GSK-3𝛽 (Ser9) in protein extracts
obtained from hippocampal slices, under basal conditions or
following KCl-induced depolarization (Figure 4). Although
total levels of these signaling proteins were not modulated
by CMS or by acute depolarization, we found that the
phosphorylation of ERK1 and ERK2 (Figures 5(a) and 5(c))
was significantly affected by stress (pERK1: 𝐹
1,11
= 41.084,
𝑃 < 0.001; pERK2: 𝐹
1,12
= 7.457, 𝑃 < 0.05; ANOVA) and
depolarization (pERK1: 𝐹
1,11
= 6.432, 𝑃 < 0.05; pERK2:
𝐹
1,11
= 1.041, 𝑃 < 0.05; ANOVA). In depth, pERK1 lev-
els (Figure 5(a)) were significantly reduced in hippocampal
slices obtained from stressed animals (pERK1 −42% versus
No Stress/KCl 5mM, 𝑃 < 0.001). Moreover, KCl-induced
depolarization increased the phosphorylated forms of both
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Figure 4: Representative Western blot analyses of the phosphorylated forms of ERK1, ERK2, and CREB (a) and of AKT and GSK3𝛽 (b) and
their total forms (a and b). 𝛽-actin was used as internal standard (c). Experimental conditions are described in Methods.
proteins in hippocampal slices obtained from unstressed rats
(Figures 5(a) and 5(c)) (pERK1 +30% versus No Stress/KCl
5mM, 𝑃 < 0.05; pERK2 +32% versus No Stress/KCl 5mM,
𝑃 < 0.05; SCPHT), but not in slices obtained from animals
exposed to CMS.
Moreover, we investigated the expression levels and the
activation (Ser133 phosphorylation) (Figures 5(e) and 5(f)) of
the transcription factor CREB, which is a crucial downstream
element in BDNF-related signaling and a positive regulator
of neurotrophin transcription [7]. We observed that both
CMS and the acute depolarization displayed significant main
effects on pCREB (𝐹
1,10
= 58.179, 𝑃 < 0.001 and 𝐹
1,10
=
58.179, 𝑃 < 0.05, resp.). Similar to what was observed
for total BDNF and isoform IV expression, pCREB levels
were reduced in slices obtained from stressed rats (−32%
versus No Stress/KCl 5mM, 𝑃 < 0.001, SCPHT), whereas
they were increased in response to depolarization only in
control animals (+25% versus No Stress/KCl 5mM, 𝑃 < 0.05;
Figure 5(e)). Any effect on the levels of the total formofCREB
(Figure 5(f)) was found.
Conversely, neither chronic stress nor the acute depolar-
ization was able to modulate the phosphorylation and the
total levels of AKT or GSK-3𝛽 in the hippocampal slices
(Figure 6).
4. Discussion
Theresults of our experiments disclose a novel and functional
level of regulation of BDNF transcription by chronic stress.
Indeed our data demonstrate not only that CMS paradigm
affects basal BDNF expression but also that it has functional
consequences on its activity-dependent regulation.
Different studies have examined the regulation of Bdnf
under chronic stress, a condition that may reproduce key
features of depression [22]. The interpretation of these data
is not univocal, since, sometimes, opposite results have
emerged based on differences in the experimental paradigm,
including timing, length, and type of stressors used [23, 24].
For example, it has been showed [24] that 3 weeks of stress
induced a significant increase of the protein levels of BDNF
in hippocampus. Even if this effect might seem to be in
contrast with our results, several reasons could explain this
discrepancy, such as the different stability of the mRNA
compared to protein. Another possibility could be that the
stress exposure may induce an increase of the translation
rate leading to a decrease of mRNA and a concomitant
upregulation of the protein levels. Anyway, as explained
below, also in the paper of Naert and colleagues [24] the
prolonged stress altered the response to a subsequent acute
challenge [24] that induced a decrease of BDNF protein levels
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Figure 5: Protein analyses of BDNF mediated signaling: ERK1/2 kinases and CREB.The protein levels of the phosphorylated forms of ERK1
(a), ERK2 (c), and CREB (e) and their total forms (b, d, and f, resp.) weremeasured byWestern blot analyses on protein extracts obtained from
hippocampal slices obtained from unstressed (No Stress) or chronically stressed (Stress) rats exposed to KCl-induced depolarization (KCl
50mM).Thedata, shown as a percentage referring to control group (NoStress/KCl 5 nM), are themean± SEMof independent determinations.
∗
𝑃 < 0.05, ∗∗∗𝑃 < 0.001 versus No Stress animals/KCl 5 nM. Two-way ANOVA with SCPHT.
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Figure 6: Protein analyses of BDNF mediated signaling: AKT and GSK3𝛽. The protein levels of the phosphorylated forms of AKT (a) and
GSK3𝛽 (c) and their total forms (b and d, resp.) were measured by Western blot analyses on protein extracts obtained from hippocampal
slices obtained from unstressed (No Stress) or chronically stressed (Stress) rats exposed to KCl-induced depolarization (KCl 50mM). The
data, shown as a percentage referring to control group (No Stress/KCl 5 nM), are the mean ± SEM of independent determinations. Two-way
ANOVA.
(while, according to our data, an increase was observed in the
control rats).
Our results are in line with the “classic” view, according
to which CMS may lead to functional impairment through
a decreased expression of neurotrophic molecules, such as
BDNF [25].
However, our study provides evidence for a novel degree
of regulation, demonstrating that activity-dependent modu-
lation of the neurotrophin is impaired in the hippocampus of
CMS rats. Since activity-dependent transcription represents
a plastic mechanism for sustaining specific neurotrophin
functions such as cognition, learning, and memory [26], the
impairment of such mechanism in CMS rats may contribute
to reduced plasticity and diminished ability to cope with
under challenging conditions. Such defect is primarily
sustained by changes in the modulation of exon IV, the major
activity-dependent transcript in the hippocampus [15] whose
deficits have been associated with a depressive phenotype
[27, 28]. Indeed, while basal effect of CMS on total Bdnf
reflects parallel modulation of all the isoforms examined,
their analysis, following neuronal activation, provides
further insight into mechanisms that may be affected by
CMS. Only the expression profile of isoform IV completely
reflects the modulation of total Bdnf. The increased mRNA
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levels of this transcript after depolarization are in line with
the well-characterized Ca++-dependent modulation of its
promoter [16, 29, 30] and might represent a “positive”
response to enhance specific functions. In line with this
hypothesis, results obtained in our laboratory have shown
that activity-dependent transcription of the neurotrophin
is facilitated by chronic treatment with antidepressants [21],
and isoform IV specifically participates in the restorative
properties of antidepressant in a genetic model of anxiety
and depression [31]. Among the calcium-responsive elements
mapped in Bdnf promoter IV, the cAMP/Ca++-response
element (CaRE3/CRE) appears particularly important for the
depolarization-induced transcription [17, 32, 33]. Our data
on pCREB support this mechanism and clearly show that the
activity of the transcription factor may be compromised by
chronic stress.
Chronic stress also leads to a significant impairment of
the MAPK pathway activation that represents a crucial point
of convergence between different extracellular signals. This
effect may result from reduced activity-dependent release
of BDNF as well as from depolarization-induced changes
of neurotransmitters release. Notably, the activation profile
of ERK1/ERK2 in our paradigm paralleled the modulation
of total Bdnf and of isoform IV, thus suggesting that the
changes of these kinases may contribute to the alterations
found in activity-dependent Bdnf transcription. Conversely,
any effects on the activation and on the total levels of GSK and
AKTwere observed.These results seem to be in contrast with
other studies [34–36] showing that the stress exposure influ-
ences the function of these pathways, but direct comparison
between those results and ours is not recommended because
of the different experimental conditions used.
Differently to isoform IV, isoform VI is modulated in
an opposite manner, with its transcription being upregu-
lated in CMS hippocampal slices exposed to depolarization.
This suggests that the systems responsible for isoform VI
activity-dependent transcription become more active even
though CMS per se reduces its mRNA levels. Glucocorticoid
hormones, which have an inhibitory control on exon VI
transcription [37, 38], may eventually contribute to CMS-
induced reduction. Conversely, since different intracellular
systems participate in activity-dependent transcription of
exon VI [39], it can be inferred that the enhanced levels of
its mRNA levels in stimulated slices from CMS rats might
result from the contribution and cooperation of multiple
pathways differently modulated by stress and depolarization.
A different influence of CMS on Bdnf activity-dependent
transcription was observed for isoform IXa, whose mRNA
levels were upregulated by depolarization in both unstressed
and stress rats. Given the current lack of information on
the regulation of this transcript, we cannot speculate on the
mechanisms sustaining the observed effect but only highlight
that BDNF transcripts may undergo different stress activity-
dependent changes, which may hold implications for the
diverse functions that are controlled by the neurotrophin.
To sum up, by using the ex vivo methodology of acute
stimulation of hippocampal slices, we demonstrated that
the activity-dependent modulation of BDNF expression is
significantly affected by CMS exposure, thus disclosing a
novel functional level of regulation of the neurotrophin by
chronic stress. Given the importance of neuronal activity-
regulated transcription as a critical process in synaptic and
neuronal plasticity, the ability of adverse events to differently
modify its control on individual BDNF promoters might be
a finely regulated and flexible mechanism that contributes
to long-lasting, experience-dependent changes in the hip-
pocampus. Alternatively, the different regulation of BDNF
promoters in our paradigm could result in altered translation,
trafficking, and activation of signal transduction pathways
that may eventually underline divergent consequences for
hippocampal structure and function. Further investigations
of these mechanisms may provide useful information on
upstream or downstream molecular processes that, by con-
tributing to stress-related disorders, may be a potential target
for pharmacological intervention.
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